Oregon Medical Research Center
1 clinical trials · Sponsor
◉ Watch Oregon Medical Research Center
| Record | Firm | Date |
|---|---|---|
| High Dose Risankizumab for Psoriasis (NCT05283135) | Oregon Medical Research Center | 2022-03-01 |
Track Oregon Medical Research Center automatically
Every clearance here is in the API, with alerts when new ones post.